Literature DB >> 32944356

Video-assisted thoracoscopy for lung cancer: who is the future of thoracic surgery?

Yu Jiang1,2, Zixuan Su1,2, Hengrui Liang1, Jun Liu1, Wenhua Liang1, Jianxing He1.   

Abstract

As the computer processing technique and display technology evolved dramatically, the surgical approach to early-stage non-small cell lung cancer (NSCLC) has made a rapid progress within the past few years. Currently, the gold standard for NSCLC is lobectomy. After the introduction of video-assisted thoracoscopic surgery (VATS), lung resection can now be conducted mini-invasively, enabling better prognosis for patients and better operation condition for surgeons. At the very beginning, the conventional two-dimensional (2D) system enabled operators to have a closer, magnified and illuminated view inside the body cavity than open thoracotomy. With the introduction of the glasses-assisted three-dimensional (3D) and glasses-free 3D display system, multiple viewing angles were further enhanced, thus a more stable, easier to master and less invasive video-assisted thoracoscopic surgery (VATS) appeared. However, given that the standard VATS is associated with limited maneuverability and stereoscopy, it restricts the availability in more advanced cases. Hopefully, most of the limitations of standard VATS can be overcome with the robotic-assisted thoracic surgery (RATS). The RATS system consists of a remote console and a robotic unit with 3 or 4 arms that can duplicate surgeons' movements. Also, it provides a magnified, 3D and high definition (HD) operation field to surgeons, allowing them to perform more complicated procedures. Apart from these, some new technologies are also invented in combination with the existing surgery system to solve difficult problems. It is hoped that the higher costs of innovative surgical technique can be offset by the better patient outcomes and improved benefits in cost-effectiveness. 2020 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  2D; 3D; Video-assisted thoracic surgery (VATS); glass-free; robotic-assisted thoracic surgery (RATS)

Year:  2020        PMID: 32944356      PMCID: PMC7475530          DOI: 10.21037/jtd-20-1116

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


Lung cancer is one of the most commonly diagnosed cancer with an estimated 228,820 new cases in 2020, representing 12.67% of all new cancer cases (1). According to a systemic global cancer study, lung cancer is the main cause for cancer deaths, with 1.9 million deaths worldwide (2). Due to the high incidence and mortality, lung cancer has become a heavy burden on public health. However, with the extensive use of low-dose computed tomographic screening, more patients with operable lung cancer (stages IA–IIIA) can be diagnosed at an early stage. Additionally, with the revolution of surgical interventions and development of chemotherapy and radiotherapy, the 5-year survival for lung cancer cases is further improving. For the treatment of lung cancer, video-assisted thoracic surgery (VATS) is of prime significance. In the 1990s, the introduction of VATS launched a new era in the diagnosis and treatment of thoracic diseases (3). During the past 30 years, continuous efforts on technical enhancement and surgical instruments advancement have been made to simplify the surgical procedure, lessen the resection area while maintaining the same therapeutic effect and improve the long-term survival as well as short-term complications from the surgery. In 2012, VATS was adopted in lung cancer diagnosis and treatment in accordance with the guidelines released by the US National Comprehensive Cancer Network (NCCN). Currently, traditional two-dimensional (2D) technology, 3D high-definition (HD) video technology, multi-view glasses-free 3D display system and robotic-assisted thoracic surgery (RATS) system are applied in thoracic surgery, enabling a less invasive, more advanced and more personalized treatments for thoracic disorders (4). In consideration of the mentioned progress in thoracic surgery for lung cancer, we now pose the question: who is the future of thoracic surgery? In this paper, we will review the history of lung cancer surgery, discuss current surgical technologies and put forward potential future directions.

2D VATS system

Since the surgical procedures in VATS are fundamentally different from that in thoracotomy, a phenomenal interest regarding minimization of the invasiveness of thoracic surgery was generated. In VATS, surgeons make multiple small incisions to pass the rigid straight instruments and the endoscope camera without removing or stretching the ribs, so it avoids injuries to muscle related to respiration and minimizes the loss of lung function. Also, the view in VATS is from anterior hilum to posterior hilum, while the open thoracotomy view is looking down at the lung from above (4). Compared to open thoracotomy, such procedures in VATS are found to be safe, feasible, reliable and cost effective (5). What’s more, VATS lobectomy is associated with fewer pulmonary comorbidities, decreased intraoperative blood loss and postoperative pain, lower morbidity and shorter time of hospital stay while maintaining similar oncologic outcomes with open thoracotomy (6-8). In addition, for those patients who encounter limited lung functions or additional complications, it is also beneficial to utilize VATS in lung cancer treatment (9-11). Based on the superiority of VATS, it is widely considered to be the gold standard for early-stage non-small cell lung cancer (NSCLC) treatment (3). To perform thoracic surgery in a safe and straightforward manner, standardized procedures and operative schemes must be followed. The process of obtaining experience and enhancing skills in surgery is called the “learning curve”. However, owing to the poor mobility of the rigid and straight instruments, conventional 2D VATS is inferior when it comes to fine vascular or nodal dissection, large tumors resection, tying and suturing (4). Besides, it lacks a 3D sense of anatomical structures, resulting in the absence of depth perception and spatial orientation. Hence, it is difficult for surgeons to identify the accurate position and distance between surgical instruments and the target (12), and it poses a great challenge for proficient surgeons in adapting the 2D VATS system, not to mention inexperienced novice. Although some surgeons criticized traditional 2D VATS as a technically limited approach for treatment, thanks to the wide dissemination of this technique, some operators are quite adept in it and even applied this system in more complicated cases. Notably, conventional VATS is conducted through two to four incisions, including an observation port for the endoscope camera and the others for the operation devices (13). In uniportal VATS, major surgical procedures are performed via a single small incision of about 3–5 cm. In the last decade, it was remarkably developed and became increasingly popular worldwide a novel approach to operate early stage lung cancer (14-16). It was demonstrated in a number of studies that uniportal VATS represents less surgical trauma and postoperative pain than traditional VATS, suggesting a faster recovery for patients (17,18). Nonetheless, on account of the limited quantity and quality of relative researches, it remains premature to show superiority for uniportal VATS. We proposed that longer follow-up and more rigorous randomized controlled trials (RCTs) should be conducted to provide adequate evidence on this issue. Given that uniportal VATS is a challenging approach, a long-term training is essential for surgeons to get accustomed to the instruments and improve proficiency.

3D VATS system

As the video imaging and endoscopic technology continue to evolve, the first 3D endoscopic system has been proposed as an approach to enhance surgical performance. However, because of the heavy, bulky head-mounted devices and low quality of 3D imaging, it soon led to surgeons’ headaches and ocular fatigue. Thus, the 3D VATS system could not be widely implemented at that time. As the 3D technology matured, novel 3D HD imaging systems enable significantly improved video quality and higher resolution via polarimetric glasses, which are lighter and more comfortable than the first-generation 3D endoscopic system was used. Nowadays, the 3D-HD VATS system has been adopted by a growing number of surgeons. As an emerging thoracic surgical system and technique, 3D VATS system is correlated with a much stronger sense of depth perception, spatial location of the target and adjacent anatomic structures, resulting in higher precision of surgical performance (19). Likewise, more sophisticated tasks including suturing, ligation and bronchial or vessel sleeve resection can be performed more easily, effectively and precisely (20,21). Overall, compared with 2D VATS system, shorter operation times, less blood loss, lower incidence of surgical trauma and shorter postoperative hospital stay were observed while the perioperative morbidity, chest drainage volume, chest drainage duration and the number of retrieved lymph nodes were comparable between the two systems (22). In terms of the hospitalization costs of 2D and 3D VATS, no additional medical expenses are demanded, which is a superiority for Chinese patients with the national medical insurance. For surgeons, especially for beginners with no need to adapt the conversion from 2D to 3D imaging, 3D views might be beneficial to shortening their learning curves. Consequently, attending a 3D system-simulated training course appears to improve proficiency, minimize the incidence of mistakes and accelerate acquisition of basic skills for thoracoscopic surgery (23). Such advanced training renders the surgeon and surgical team self-assurance when operating in confined intracavitary space. As to the adverse effects of 3D VATS, it poses a great challenge to both surgeons and camera assistants. As we all know, the principle of the 3D display lies in the human eye parallax theory. When we watch a 3D image, different images enter our eyes through the polarizing filter glasses respectively. After the brain analyzes and synthesizes the image, a 3D vision is formed. During the operation, the eyes and the brain are working intensely, making some surgeons unable to work with 3D VATS system for a long time. In addition, the magnification of 3D VATS system is greatly larger than that of 2D system. Also, the polarizer could trigger a relatively dark operative field. In this situation, it is likely to increase the surgical difficulty due to a much smaller and darker visual field from the same distance. Notably, unlike the conventional 2D VATS system, lens can only be rotated manually in 3D VATS system, causing a shifting vision in the screen. If the frames move too fast, surgeons may well have difficulty in adapting to a rotated view, leading to headache, eye fatigue, dizziness, nauseous and vomiting. Meanwhile, a clear and stainless lens is in greater demand in 3D system, otherwise it may cause vertigo and nausea for surgeons as well. Hence, it puts forward a higher demand on camera assistants when providing a steady vision for surgeons because the hand shanks of 3D VATS systems are heavier than that in 2D system (24). For those who are not accustomed to wearing glasses, it is also uncomfortable to wear 3D glasses during the operation, for reasons such as, blurred vision due to exhalation, or the discomfort on the nose and ears. The 3D HD system, which combines the cost effectiveness of the 2D VATS system with the 3D imaging technology of the da Vinci Surgical System, may be an appropriate intermediate choice between the conventional 2D VATS and RATS at present, especially for patients in developing countries. In the near future, 3D VATS system has potential to be an incentive for improvement in minimally invasive thoracic surgery, enabling more complicated operations to be performed with better therapeutic efficacy.

Glasses-free 3D VATS

The glasses-free 3D VATS system is an update of conventional 3D VATS system. As an innovative technology, it gets rid of the shackles of 3D glasses and utilizes a head band worn by the surgeon and two sensors on the screen to acquire 3D images. Although the environment for thoracoscopic surgery is complicated, with the help of both face-tracking and eye-positioning techniques, glasses-free 3D system can trace the movements of surgeons in real-time and provide a smooth 3D HD visual fields at any angle (12). However, it remains controversial when it comes to the clinical effectiveness of glasses-free 3D VATS system. A retrospective study compared the effects of glasses-free 3D VATS and conventional 2D thoracoscopic radical surgery on lung cancer. There were no significant differences in intraoperative indicators (mean number of lymph nodes dissected, incidence of massive bleeding, rate of conversion to thoracotomy and total amount of blood loss), postoperative indicators (volume of chest drainage, drainage days, and complications such as pneumonia and atelectasis) or postoperative systemic inflammation (decreased leukocytes and elevated body temperature) (12). Nonetheless, another clinical research indicated that glasses-free 3D system has potential benefits of less intraoperative bleeding, lower chest tube placement rate and shorter hospital stays (25). To further identify the clinical efficacy and the cost benefic of glasses-free 3D VATS, more in-depth researches including multi-center large-scale RCTs with more objective and rigorous clinical outcomes still deserve further investigation. Concerning the learning curve, visual field brightness in glasses-free 3D system is increased, thus beginners can more easily get accustomed to the surgical vision and enhance hand-eye coordination in a shorter amount of time, thereby shortening the learning process. Nonetheless, the system only follows movements of the main operator, the other medical staff must wear the traditional polarized glasses to watch the 3D images on an additional. Similar to the traditional 3D VATS system, the viewing lens have a relatively fixed position. If there is an obstacle in front of the lens, the camera assistant has to rotate the camera body manually, causing dizziness, nauseous visual fatigue on surgeons as a result. Furthermore, even if the crosstalk rate has been reduced to 4%, image ghosting still needs to be eliminated in future development. Generally, glasses-free 3D VATS is a brand-new resource for thoracic surgeons. Nevertheless, it remains in the early stages of development. Therefore, a wide-angle, high-resolution, multi-view glasses-free 3D system should be encouraged to be widely applied in minimally invasive thoracic surgery in the near future (26).

RATS system

By combining 3D images with increased degrees of freedom, the RATS system has been proposed as a “technological disruptor” to conventional surgery approaches (4). Since it was first introduced into clinical practice in 2002, it has become progressively popular and, with the rising numbers and styles of robotic platforms to choose from, may become the most essential armamentarium for thoracic surgeons in the foreseeable future. The da Vinci Surgical System, the only robot available on the market for RATS, is the fruition of the minimally invasive surgery technique. It is composed of a robotic unit with 3 or 4 arms and a remote console. With RATS, surgeons perform an operation without necessarily at the bedside and not even sterile. Instead, the multi-angle image synthesizer in the camera arm creates a magnified and panoramic 3D HD vision while surgeons operate on the main console to dominate the other robotic arms. With the help of the highly sensitive motion trigger sensor, surgeons’ movements can be transmitted to the tips of the instruments synchronously (27), then a variety of minimally invasive instruments are used to finish the operation. For surgeons, the 3D HD imaging with depth perception guarantees the enhanced vision for fine dissection and binocular view of the whole thoracic cavity. Also, robotic instruments, with seven degrees of freedom, are able to duplicate the human-wrist movement inside the chest cavity while getting rid of surgeon tremors. As a result, it enables surgeons to perform an operation for a longer period of time with less fatigue (4). Because of its easier maneuverability, it may not require prior experience with laparoscopic or thoracoscopic surgery to get used to the system, demonstrating a better adaptability. However, the drawbacks of the da Vinci Surgical System include loss of haptic feedback and limited selection of instruments in comparison with that of thoracoscopic or open lobectomy. Consequently, as surgeons climb the learning curve in robot-assisted apparatus, they need to familiarize themselves with how to handle robotic surgical instruments and become accustomed to the absence of tactile feedback in a magnified but restricted operative field (28). As the accumulation of experience with robotic lobectomy grows, the drawbacks might become less obvious. As an alternative to standard VATS, the da Vinci Surgical System has been increasingly applied to thoracic surgeries. Much work so far has focused on the safety and efficacy of open thoracotomy, VATS and RATS. Several studies proposed that the outcomes of the robotic technique contain smaller incisions, lower conversion rate to open surgery, decreased postoperative pain, shorter time of laying up, less incidence of complications, faster recovery, higher survival but longer operative time compared to conventional open thoracotomy (29,30). Nonetheless, given that most of the previous studies were based on retrospective observational studies and no large-scale RCTs have devoted to the comparison of various surgical approaches, the equivalence of long-term oncologic outcomes and cost effectiveness between RATS and VATS remains controversial (31,32). What’s more, the high costs caused by implementation and maintenance have hindered robotic technology and surgery from becoming a widely used system. Hopefully, we can then anticipate that the competition and collaboration between the increasing manufacturing companies and academic institutions will contribute to decreasing the overall costs of RATS in the future. The latest generation system, da Vinci Xi, was launched in 2014 with a concise docking, a more user-friendly design and laser guidance. In this system, a digital end-mounted camera with autofocus was installed on the thoracoscope for ameliorating the vision, enabling the ports to placed relatively close together but still avoid collision (28). To date, the surgical robots are mostly assembled from rigid components and have relatively limited telescopic bending capabilities. The Flex Robotic System is the representative of the soft robotic platform, another interesting area of the future. It is featured by higher telescopic ability and easier access to difficult-to-reach regions of the body, thus making natural orifice endoscopic surgery possible (33). The softness and flexibility are both their merits and their weaknesses, so it calls for a balance between the rigidity of the instruments and the difficulty of manipulation (26). At present, some of these soft robots are in development, and the Flex Robotic System, is conducting human trials, particularly in the domain of transoral robotic surgery (34,35). As the robotic system evolves at a staggering pace, single-incision robotic chest surgery will be more and more widely applied in the years to come, resulting in safer, less painful, and superior efficacy operations for patients (36,37). In conclusion, RATS is supposed to be a feasible and safe technology, with at least equivalent surgical efficacy with VATS. Besides, with the superiority in dexterity and stereoscopy, it is also an evolving field which allows more complex and precise procedures in narrow spaces in the thoracic cavity. Concerns of operative time and overall costs will be addressed by better proficiency of surgical team and the evolution of instruments, becoming more competitive with VATS. However, the related indication of RATS based on strong evidence are still vague. Therefore, it is still a challenge to set up the rigorous eligibility criteria and explicit definition of outcomes. Apart from these, the benefits between RATS and VATS is still a topic of debate and further studies are warranted to better define its potential the strengths and weaknesses.

Conclusions

Based on the mentioned progress in thoracic surgery for NSCLC, we propose that the glass-free 3D VATS system and RATS system have potential to be the mainstream approaches for future minimally-invasive thoracic surgery, with great economic and social benefits. Even though they are very promising, the authors consider they are still too early to be widely disseminated as routine surgical procedures currently. To further evaluate their feasibility, necessity and cost-effectiveness, more objective and clinically relevant outcomes by rigorous design clinical trials are indispensable before extensive usage. It can be foreseen that the field of surgical technology will continue to make enormous strides. For instance, custom-designed light detection and ranging (LiDAR) scanner, electromagnetic navigational localization and 3D reconstruction can be implemented to further enhance the ability to localize and process the specific target. Besides, with the help of the coming 5G technology, if real-time 4k imaging technique was available, the quality of stereoscopic images will become even better. For RATS, surgeons have no direct contact with the tissues and only count on visual cues to evaluate consistency and tension, which is both the advantage and drawback. Correspondingly, another possible improvement may lie in the virtual haptic feedback for robotic surgeons. In recent years, new inventions appear almost as fast as the demand for them. To this end, more surgeons, engineers and scientists will continue to collaborate in terms of evolution of more advanced technology. The article’s supplementary files as
  37 in total

1.  Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial.

Authors:  Morten Bendixen; Ole Dan Jørgensen; Christian Kronborg; Claus Andersen; Peter Bjørn Licht
Journal:  Lancet Oncol       Date:  2016-05-06       Impact factor: 41.316

2.  Subxiphoid or subcostal uniportal robotic-assisted surgery: early experimental experience.

Authors:  Diego Gonzalez-Rivas; Mahmoud Ismail
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

Review 3.  Updates on Minimally Invasive Surgery in Non-Small Cell Lung Cancer.

Authors:  Norihiko Ikeda
Journal:  Curr Treat Options Oncol       Date:  2019-02-11

4.  Three-Dimensional Versus Two-Dimensional Video-Assisted Endoscopic Surgery: A Meta-analysis of Clinical Data.

Authors:  Hengrui Liang; Wenhua Liang; Zhao Lei; Zhichao Liu; Wei Wang; Jiaxi He; Yuan Zeng; Weizhe Huang; Manting Wang; Yuehan Chen; Jianxing He
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

Review 5.  VATS-based approach for robotic lobectomy.

Authors:  Franca M A Melfi; Olivia Fanucchi; Federico Davini; Alfredo Mussi
Journal:  Thorac Surg Clin       Date:  2014-05       Impact factor: 1.750

6.  Future of uniportal video-assisted thoracoscopic surgery-emerging technology.

Authors:  Zheng Li; Calvin S H Ng
Journal:  Ann Cardiothorac Surg       Date:  2016-03

7.  Novice surgeons: do they benefit from 3D laparoscopy?

Authors:  Mehmet Özsoy; Panagiotis Kallidonis; Iason Kyriazis; Vasileios Panagopoulos; Marinos Vasilas; George C Sakellaropoulos; Evangelos Liatsikos
Journal:  Lasers Med Sci       Date:  2015-03-15       Impact factor: 3.161

8.  The feasibility and advantage of uniportal video-assisted thoracoscopic surgery (VATS) in pulmonary lobectomy.

Authors:  Linlin Wang; Dabei Liu; Jibin Lu; Suning Zhang; Xueying Yang
Journal:  BMC Cancer       Date:  2017-01-25       Impact factor: 4.430

9.  Glasses-free 3D versus 2D video-assisted thoracoscopic thymectomy: a single-center short-term comparative study.

Authors:  Xukai Li; Fei Cui; Tuo Xing; Ying Huang; Jinghui Deng; Zhexue Hao; Jun Liu; Jianxing He
Journal:  Ann Transl Med       Date:  2019-12

10.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.

Authors:  Christina Fitzmaurice; Degu Abate; Naghmeh Abbasi; Hedayat Abbastabar; Foad Abd-Allah; Omar Abdel-Rahman; Ahmed Abdelalim; Amir Abdoli; Ibrahim Abdollahpour; Abdishakur S M Abdulle; Nebiyu Dereje Abebe; Haftom Niguse Abraha; Laith Jamal Abu-Raddad; Ahmed Abualhasan; Isaac Akinkunmi Adedeji; Shailesh M Advani; Mohsen Afarideh; Mahdi Afshari; Mohammad Aghaali; Dominic Agius; Sutapa Agrawal; Ayat Ahmadi; Elham Ahmadian; Ehsan Ahmadpour; Muktar Beshir Ahmed; Mohammad Esmaeil Akbari; Tomi Akinyemiju; Ziyad Al-Aly; Assim M AlAbdulKader; Fares Alahdab; Tahiya Alam; Genet Melak Alamene; Birhan Tamene T Alemnew; Kefyalew Addis Alene; Cyrus Alinia; Vahid Alipour; Syed Mohamed Aljunid; Fatemeh Allah Bakeshei; Majid Abdulrahman Hamad Almadi; Amir Almasi-Hashiani; Ubai Alsharif; Shirina Alsowaidi; Nelson Alvis-Guzman; Erfan Amini; Saeed Amini; Yaw Ampem Amoako; Zohreh Anbari; Nahla Hamed Anber; Catalina Liliana Andrei; Mina Anjomshoa; Fereshteh Ansari; Ansariadi Ansariadi; Seth Christopher Yaw Appiah; Morteza Arab-Zozani; Jalal Arabloo; Zohreh Arefi; Olatunde Aremu; Habtamu Abera Areri; Al Artaman; Hamid Asayesh; Ephrem Tsegay Asfaw; Alebachew Fasil Ashagre; Reza Assadi; Bahar Ataeinia; Hagos Tasew Atalay; Zerihun Ataro; Suleman Atique; Marcel Ausloos; Leticia Avila-Burgos; Euripide F G A Avokpaho; Ashish Awasthi; Nefsu Awoke; Beatriz Paulina Ayala Quintanilla; Martin Amogre Ayanore; Henok Tadesse Ayele; Ebrahim Babaee; Umar Bacha; Alaa Badawi; Mojtaba Bagherzadeh; Eleni Bagli; Senthilkumar Balakrishnan; Abbas Balouchi; Till Winfried Bärnighausen; Robert J Battista; Masoud Behzadifar; Meysam Behzadifar; Bayu Begashaw Bekele; Yared Belete Belay; Yaschilal Muche Belayneh; Kathleen Kim Sachiko Berfield; Adugnaw Berhane; Eduardo Bernabe; Mircea Beuran; Nickhill Bhakta; Krittika Bhattacharyya; Belete Biadgo; Ali Bijani; Muhammad Shahdaat Bin Sayeed; Charles Birungi; Catherine Bisignano; Helen Bitew; Tone Bjørge; Archie Bleyer; Kassawmar Angaw Bogale; Hunduma Amensisa Bojia; Antonio M Borzì; Cristina Bosetti; Ibrahim R Bou-Orm; Hermann Brenner; Jerry D Brewer; Andrey Nikolaevich Briko; Nikolay Ivanovich Briko; Maria Teresa Bustamante-Teixeira; Zahid A Butt; Giulia Carreras; Juan J Carrero; Félix Carvalho; Clara Castro; Franz Castro; Ferrán Catalá-López; Ester Cerin; Yazan Chaiah; Wagaye Fentahun Chanie; Vijay Kumar Chattu; Pankaj Chaturvedi; Neelima Singh Chauhan; Mohammad Chehrazi; Peggy Pei-Chia Chiang; Tesfaye Yitna Chichiabellu; Onyema Greg Chido-Amajuoyi; Odgerel Chimed-Ochir; Jee-Young J Choi; Devasahayam J Christopher; Dinh-Toi Chu; Maria-Magdalena Constantin; Vera M Costa; Emanuele Crocetti; Christopher Stephen Crowe; Maria Paula Curado; Saad M A Dahlawi; Giovanni Damiani; Amira Hamed Darwish; Ahmad Daryani; José das Neves; Feleke Mekonnen Demeke; Asmamaw Bizuneh Demis; Birhanu Wondimeneh Demissie; Gebre Teklemariam Demoz; Edgar Denova-Gutiérrez; Afshin Derakhshani; Kalkidan Solomon Deribe; Rupak Desai; Beruk Berhanu Desalegn; Melaku Desta; Subhojit Dey; Samath Dhamminda Dharmaratne; Meghnath Dhimal; Daniel Diaz; Mesfin Tadese Tadese Dinberu; Shirin Djalalinia; David Teye Doku; Thomas M Drake; Manisha Dubey; Eleonora Dubljanin; Eyasu Ejeta Duken; Hedyeh Ebrahimi; Andem Effiong; Aziz Eftekhari; Iman El Sayed; Maysaa El Sayed Zaki; Shaimaa I El-Jaafary; Ziad El-Khatib; Demelash Abewa Elemineh; Hajer Elkout; Richard G Ellenbogen; Aisha Elsharkawy; Mohammad Hassan Emamian; Daniel Adane Endalew; Aman Yesuf Endries; Babak Eshrati; Ibtihal Fadhil; Vahid Fallah Omrani; Mahbobeh Faramarzi; Mahdieh Abbasalizad Farhangi; Andrea Farioli; Farshad Farzadfar; Netsanet Fentahun; Eduarda Fernandes; Garumma Tolu Feyissa; Irina Filip; Florian Fischer; James L Fisher; Lisa M Force; Masoud Foroutan; Marisa Freitas; Takeshi Fukumoto; Neal D Futran; Silvano Gallus; Fortune Gbetoho Gankpe; Reta Tsegaye Gayesa; Tsegaye Tewelde Gebrehiwot; Gebreamlak Gebremedhn Gebremeskel; Getnet Azeze Gedefaw; Belayneh K Gelaw; Birhanu Geta; Sefonias Getachew; Kebede Embaye Gezae; Mansour Ghafourifard; Alireza Ghajar; Ahmad Ghashghaee; Asadollah Gholamian; Paramjit Singh Gill; Themba T G Ginindza; Alem Girmay; Muluken Gizaw; Ricardo Santiago Gomez; Sameer Vali Gopalani; Giuseppe Gorini; Bárbara Niegia Garcia Goulart; Ayman Grada; Maximiliano Ribeiro Guerra; Andre Luiz Sena Guimaraes; Prakash C Gupta; Rahul Gupta; Kishor Hadkhale; Arvin Haj-Mirzaian; Arya Haj-Mirzaian; Randah R Hamadeh; Samer Hamidi; Lolemo Kelbiso Hanfore; Josep Maria Haro; Milad Hasankhani; Amir Hasanzadeh; Hamid Yimam Hassen; Roderick J Hay; Simon I Hay; Andualem Henok; Nathaniel J Henry; Claudiu Herteliu; Hagos D Hidru; Chi Linh Hoang; Michael K Hole; Praveen Hoogar; Nobuyuki Horita; H Dean Hosgood; Mostafa Hosseini; Mehdi Hosseinzadeh; Mihaela Hostiuc; Sorin Hostiuc; Mowafa Househ; Mohammedaman Mama Hussen; Bogdan Ileanu; Milena D Ilic; Kaire Innos; Seyed Sina Naghibi Irvani; Kufre Robert Iseh; Sheikh Mohammed Shariful Islam; Farhad Islami; Nader Jafari Balalami; Morteza Jafarinia; Leila Jahangiry; Mohammad Ali Jahani; Nader Jahanmehr; Mihajlo Jakovljevic; Spencer L James; Mehdi Javanbakht; Sudha Jayaraman; Sun Ha Jee; Ensiyeh Jenabi; Ravi Prakash Jha; Jost B Jonas; Jitendra Jonnagaddala; Tamas Joo; Suresh Banayya Jungari; Mikk Jürisson; Ali Kabir; Farin Kamangar; André Karch; Narges Karimi; Ansar Karimian; Amir Kasaeian; Gebremicheal Gebreslassie Kasahun; Belete Kassa; Tesfaye Dessale Kassa; Mesfin Wudu Kassaw; Anil Kaul; Peter Njenga Keiyoro; Abraham Getachew Kelbore; Amene Abebe Kerbo; Yousef Saleh Khader; Maryam Khalilarjmandi; Ejaz Ahmad Khan; Gulfaraz Khan; Young-Ho Khang; Khaled Khatab; Amir Khater; Maryam Khayamzadeh; Maryam Khazaee-Pool; Salman Khazaei; Abdullah T Khoja; Mohammad Hossein Khosravi; Jagdish Khubchandani; Neda Kianipour; Daniel Kim; Yun Jin Kim; Adnan Kisa; Sezer Kisa; Katarzyna Kissimova-Skarbek; Hamidreza Komaki; Ai Koyanagi; Kristopher J Krohn; Burcu Kucuk Bicer; Nuworza Kugbey; Vivek Kumar; Desmond Kuupiel; Carlo La Vecchia; Deepesh P Lad; Eyasu Alem Lake; Ayenew Molla Lakew; Dharmesh Kumar Lal; Faris Hasan Lami; Qing Lan; Savita Lasrado; Paolo Lauriola; Jeffrey V Lazarus; James Leigh; Cheru Tesema Leshargie; Yu Liao; Miteku Andualem Limenih; Stefan Listl; Alan D Lopez; Platon D Lopukhov; Raimundas Lunevicius; Mohammed Madadin; Sameh Magdeldin; Hassan Magdy Abd El Razek; Azeem Majeed; Afshin Maleki; Reza Malekzadeh; Ali Manafi; Navid Manafi; Wondimu Ayele Manamo; Morteza Mansourian; Mohammad Ali Mansournia; Lorenzo Giovanni Mantovani; Saman Maroufizadeh; Santi Martini S Martini; Tivani Phosa Mashamba-Thompson; Benjamin Ballard Massenburg; Motswadi Titus Maswabi; Manu Raj Mathur; Colm McAlinden; Martin McKee; Hailemariam Abiy Alemu Meheretu; Ravi Mehrotra; Varshil Mehta; Toni Meier; Yohannes A Melaku; Gebrekiros Gebremichael Meles; Hagazi Gebre Meles; Addisu Melese; Mulugeta Melku; Peter T N Memiah; Walter Mendoza; Ritesh G Menezes; Shahin Merat; Tuomo J Meretoja; Tomislav Mestrovic; Bartosz Miazgowski; Tomasz Miazgowski; Kebadnew Mulatu M Mihretie; Ted R Miller; Edward J Mills; Seyed Mostafa Mir; Hamed Mirzaei; Hamid Reza Mirzaei; Rashmi Mishra; Babak Moazen; Dara K Mohammad; Karzan Abdulmuhsin Mohammad; Yousef Mohammad; Aso Mohammad Darwesh; Abolfazl Mohammadbeigi; Hiwa Mohammadi; Moslem Mohammadi; Mahdi Mohammadian; Abdollah Mohammadian-Hafshejani; Milad Mohammadoo-Khorasani; Reza Mohammadpourhodki; Ammas Siraj Mohammed; Jemal Abdu Mohammed; Shafiu Mohammed; Farnam Mohebi; Ali H Mokdad; Lorenzo Monasta; Yoshan Moodley; Mahmood Moosazadeh; Maryam Moossavi; Ghobad Moradi; Mohammad Moradi-Joo; Maziar Moradi-Lakeh; Farhad Moradpour; Lidia Morawska; Joana Morgado-da-Costa; Naho Morisaki; Shane Douglas Morrison; Abbas Mosapour; Seyyed Meysam Mousavi; Achenef Asmamaw Muche; Oumer Sada S Muhammed; Jonah Musa; Ashraf F Nabhan; Mehdi Naderi; Ahamarshan Jayaraman Nagarajan; Gabriele Nagel; Azin Nahvijou; Gurudatta Naik; Farid Najafi; Luigi Naldi; Hae Sung Nam; Naser Nasiri; Javad Nazari; Ionut Negoi; Subas Neupane; Polly A Newcomb; Haruna Asura Nggada; Josephine W Ngunjiri; Cuong Tat Nguyen; Leila Nikniaz; Dina Nur Anggraini Ningrum; Yirga Legesse Nirayo; Molly R Nixon; Chukwudi A Nnaji; Marzieh Nojomi; Shirin Nosratnejad; Malihe Nourollahpour Shiadeh; Mohammed Suleiman Obsa; Richard Ofori-Asenso; Felix Akpojene Ogbo; In-Hwan Oh; Andrew T Olagunju; Tinuke O Olagunju; Mojisola Morenike Oluwasanu; Abidemi E Omonisi; Obinna E Onwujekwe; Anu Mary Oommen; Eyal Oren; Doris D V Ortega-Altamirano; Erika Ota; Stanislav S Otstavnov; Mayowa Ojo Owolabi; Mahesh P A; Jagadish Rao Padubidri; Smita Pakhale; Amir H Pakpour; Adrian Pana; Eun-Kee Park; Hadi Parsian; Tahereh Pashaei; Shanti Patel; Snehal T Patil; Alyssa Pennini; David M Pereira; Cristiano Piccinelli; Julian David Pillay; Majid Pirestani; Farhad Pishgar; Maarten J Postma; Hadi Pourjafar; Farshad Pourmalek; Akram Pourshams; Swayam Prakash; Narayan Prasad; Mostafa Qorbani; Mohammad Rabiee; Navid Rabiee; Amir Radfar; Alireza Rafiei; Fakher Rahim; Mahdi Rahimi; Muhammad Aziz Rahman; Fatemeh Rajati; Saleem M Rana; Samira Raoofi; Goura Kishor Rath; David Laith Rawaf; Salman Rawaf; Robert C Reiner; Andre M N Renzaho; Nima Rezaei; Aziz Rezapour; Ana Isabel Ribeiro; Daniela Ribeiro; Luca Ronfani; Elias Merdassa Roro; Gholamreza Roshandel; Ali Rostami; Ragy Safwat Saad; Parisa Sabbagh; Siamak Sabour; Basema Saddik; Saeid Safiri; Amirhossein Sahebkar; Mohammad Reza Salahshoor; Farkhonde Salehi; Hosni Salem; Marwa Rashad Salem; Hamideh Salimzadeh; Joshua A Salomon; Abdallah M Samy; Juan Sanabria; Milena M Santric Milicevic; Benn Sartorius; Arash Sarveazad; Brijesh Sathian; Maheswar Satpathy; Miloje Savic; Monika Sawhney; Mehdi Sayyah; Ione J C Schneider; Ben Schöttker; Mario Sekerija; Sadaf G Sepanlou; Masood Sepehrimanesh; Seyedmojtaba Seyedmousavi; Faramarz Shaahmadi; Hosein Shabaninejad; Mohammad Shahbaz; Masood Ali Shaikh; Amir Shamshirian; Morteza Shamsizadeh; Heidar Sharafi; Zeinab Sharafi; Mehdi Sharif; Ali Sharifi; Hamid Sharifi; Rajesh Sharma; Aziz Sheikh; Reza Shirkoohi; Sharvari Rahul Shukla; Si Si; Soraya Siabani; Diego Augusto Santos Silva; Dayane Gabriele Alves Silveira; Ambrish Singh; Jasvinder A Singh; Solomon Sisay; Freddy Sitas; Eugène Sobngwi; Moslem Soofi; Joan B Soriano; Vasiliki Stathopoulou; Mu'awiyyah Babale Sufiyan; Rafael Tabarés-Seisdedos; Takahiro Tabuchi; Ken Takahashi; Omid Reza Tamtaji; Mohammed Rasoul Tarawneh; Segen Gebremeskel Tassew; Parvaneh Taymoori; Arash Tehrani-Banihashemi; Mohamad-Hani Temsah; Omar Temsah; Berhe Etsay Tesfay; Fisaha Haile Tesfay; Manaye Yihune Teshale; Gizachew Assefa Tessema; Subash Thapa; Kenean Getaneh Tlaye; Roman Topor-Madry; Marcos Roberto Tovani-Palone; Eugenio Traini; Bach Xuan Tran; Khanh Bao Tran; Afewerki Gebremeskel Tsadik; Irfan Ullah; Olalekan A Uthman; Marco Vacante; Maryam Vaezi; Patricia Varona Pérez; Yousef Veisani; Simone Vidale; Francesco S Violante; Vasily Vlassov; Stein Emil Vollset; Theo Vos; Kia Vosoughi; Giang Thu Vu; Isidora S Vujcic; Henry Wabinga; Tesfahun Mulatu Wachamo; Fasil Shiferaw Wagnew; Yasir Waheed; Fitsum Weldegebreal; Girmay Teklay Weldesamuel; Tissa Wijeratne; Dawit Zewdu Wondafrash; Tewodros Eshete Wonde; Adam Belay Wondmieneh; Hailemariam Mekonnen Workie; Rajaram Yadav; Abbas Yadegar; Ali Yadollahpour; Mehdi Yaseri; Vahid Yazdi-Feyzabadi; Alex Yeshaneh; Mohammed Ahmed Yimam; Ebrahim M Yimer; Engida Yisma; Naohiro Yonemoto; Mustafa Z Younis; Bahman Yousefi; Mahmoud Yousefifard; Chuanhua Yu; Erfan Zabeh; Vesna Zadnik; Telma Zahirian Moghadam; Zoubida Zaidi; Mohammad Zamani; Hamed Zandian; Alireza Zangeneh; Leila Zaki; Kazem Zendehdel; Zerihun Menlkalew Zenebe; Taye Abuhay Zewale; Arash Ziapour; Sanjay Zodpey; Christopher J L Murray
Journal:  JAMA Oncol       Date:  2019-12-01       Impact factor: 31.777

View more
  3 in total

1.  Robotic-assisted thoracic surgery reduces perioperative complications and achieves a similar long-term survival profile as posterolateral thoracotomy in clinical N2 stage non-small cell lung cancer patients: a multicenter, randomized, controlled trial.

Authors:  Jia Huang; Yu Tian; Chongwu Li; Yaofeng Shen; Hecheng Li; Fanzhen Lv; Hao Lin; Peiji Lu; Jules Lin; Christopher Lau; Ricardo Mingarini Terra; Long Jiang; Qingquan Luo
Journal:  Transl Lung Cancer Res       Date:  2021-11

Review 2.  Photodynamic therapy of lung cancer, where are we?

Authors:  Anine Crous; Heidi Abrahamse
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

3.  Effect and feasibility of uniportal thoracoscopic surgery in the treatment of early-stage lung cancer in a primary hospital.

Authors:  Xiaoping Zuo; Guofeng Liu; Xiaochuan Liu; Yongjian Feng; Haijun Zhang
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.